Dm. Keeling et al., ROLE OF BETA(2)-GLYCOPROTEIN-I AND ANTIPHOSPHOLIPID ANTIBODIES IN ACTIVATION OF PROTEIN-C IN-VITRO, Journal of Clinical Pathology, 46(10), 1993, pp. 908-911
Aims-To investigate the effect of beta2-glycoprotein I (beta2 GPI) on
the thrombin/thrombomodulin dependent activation of protein C; and to
determine whether beta2 GPI dependent anticardiolipin antibodies have
any effect. Methods-Protein C was activated by thrombin in the presenc
e of thrombomodulin and phospholipid vesicles in an in vitro system. T
he effect of adding purified beta2 GPI to this system was observed. Af
finity purified anticardiolipin antibodies and total IgG from patients
with anticardiolipin antibodies and the lupus anticoagulant were stud
ied for their effects on protein C activation in the presence and abse
nce of beta2 GPI. Results-beta2-Glycoprotein I had no effect on the ac
tivity of preformed activated protein C. When the phospholipid vesicle
s were incubated with beta2 GPI before the addition of protein C, the
activation of protein C was inhibited in a dose dependent manner. With
phosphatidylserine:phosphatidylcholine vesicles at a concentration of
1 muM:2 muM, beta2 GPI began to inhibit the reaction at a concentrati
on of 15 nM, and at 4 muM (the normal plasma concentration) the activa
tion of protein C was reduced to 40%. Anticardiolipin antibodies had n
o demonstrable effect. Conclusions-beta2-Glycoprotein I inhibits prote
in C activation in an in vitro system. Its physiological role is unkno
wn but it has potential procoagulant as well as anticoagulant properti
es. An effect of antiphospholipid antibodies on protein C activation,
which might explain their association with thrombosis, could not be sh
own.